These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
87. Effects of dietary cholesterol and simvastatin on cholesterol synthesis in Smith-Lemli-Opitz syndrome. Chan YM; Merkens LS; Connor WE; Roullet JB; Penfield JA; Jordan JM; Steiner RD; Jones PJ Pediatr Res; 2009 Jun; 65(6):681-5. PubMed ID: 19430384 [TBL] [Abstract][Full Text] [Related]
88. Effects of the membrane dipole potential on the interaction of saquinavir with phospholipid membranes and plasma membrane receptors of Caco-2 cells. Asawakarn T; Cladera J; O'Shea P J Biol Chem; 2001 Oct; 276(42):38457-63. PubMed ID: 11500495 [TBL] [Abstract][Full Text] [Related]
89. Biochemical and genetic aspects of 7-dehydrocholesterol reductase and Smith-Lemli-Opitz syndrome. Waterham HR; Wanders RJ Biochim Biophys Acta; 2000 Dec; 1529(1-3):340-56. PubMed ID: 11111101 [TBL] [Abstract][Full Text] [Related]
90. Defective conversion of 7-dehydrocholesterol to cholesterol in cultured skin fibroblasts from Smith-Lemli-Opitz syndrome homozygotes. Honda A; Tint GS; Salen G; Batta AK; Chen TS; Shefer S J Lipid Res; 1995 Jul; 36(7):1595-601. PubMed ID: 7595082 [TBL] [Abstract][Full Text] [Related]
91. Simvastatin. A new therapeutic approach for Smith-Lemli-Opitz syndrome. Jira PE; Wevers RA; de Jong J; Rubio-Gozalbo E; Janssen-Zijlstra FS; van Heyst AF; Sengers RC; Smeitink JA J Lipid Res; 2000 Aug; 41(8):1339-46. PubMed ID: 10946022 [TBL] [Abstract][Full Text] [Related]
93. Desmosterol replaces cholesterol for ligand binding function of the serotonin(1A) receptor in solubilized hippocampal membranes: support for nonannular binding sites for cholesterol? Singh P; Jafurulla M; Paila YD; Chattopadhyay A Biochim Biophys Acta; 2011 Oct; 1808(10):2428-34. PubMed ID: 21763272 [TBL] [Abstract][Full Text] [Related]
94. Identification of 19-nor-5,7,9(10)-cholestatrien-3 beta-ol in patients with Smith-Lemli-Opitz syndrome. Batta AK; Salen G; Tint GS; Shefer S J Lipid Res; 1995 Nov; 36(11):2413-8. PubMed ID: 8656079 [TBL] [Abstract][Full Text] [Related]
95. Probes for protein adduction in cholesterol biosynthesis disorders: Alkynyl lanosterol as a viable sterol precursor. Tallman KA; Kim HH; Korade Z; Genaro-Mattos TC; Wages PA; Liu W; Porter NA Redox Biol; 2017 Aug; 12():182-190. PubMed ID: 28258022 [TBL] [Abstract][Full Text] [Related]
96. Cholesterol metabolism in the RSH/Smith-Lemli-Opitz syndrome: summary of an NICHD conference. Opitz JM; de la Cruz F Am J Med Genet; 1994 May; 50(4):326-38. PubMed ID: 7632194 [TBL] [Abstract][Full Text] [Related]
97. A certain proportion of docosahexaenoic acid tends to revert structural and dynamical effects of cholesterol on lipid membranes. Pedroni VI; Sierra MB; Alarcón LM; Verde AR; Appignanesi GA; Morini MA Biochim Biophys Acta Biomembr; 2021 Jun; 1863(6):183584. PubMed ID: 33571481 [TBL] [Abstract][Full Text] [Related]
98. Role of Cholesterol and its Biosynthetic Precursors on Membrane Organization and Dynamics: A Fluorescence Approach. Shrivastava S; Paila YD; Chattopadhyay A J Membr Biol; 2023 Apr; 256(2):189-197. PubMed ID: 36781437 [TBL] [Abstract][Full Text] [Related]
99. C-Glucosylation as a tool for the prevention of PAINS-induced membrane dipole potential alterations. de Matos AM; Blázquez-Sánchez MT; Sousa C; Oliveira MC; de Almeida RFM; Rauter AP Sci Rep; 2021 Feb; 11(1):4443. PubMed ID: 33627687 [TBL] [Abstract][Full Text] [Related]
100. Non-destructive real-time monitoring and investigation of the self-assembly process using fluorescent probes. Ji X; Wang N; Wang J; Wang T; Huang X; Hao H Chem Sci; 2024 Mar; 15(11):3800-3830. PubMed ID: 38487216 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]